Nanoparticle Vector for RNA Self-Delivery in Bone Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional bone tissue repair materials have limited application range and cause toxic and side effects, hindering effective cartilage and bone tissue repair.
Innovation Solution
A nanoparticle vector for RNA self-delivery is developed, comprising a β-cyclodextrin-RNA conjugate, an adamantane-ligand conjugate, and a cationic polymer, which enables targeted and efficient delivery of siRNA or microRNA for gene silencing and tissue repair without toxic side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional bone tissue repair materials are used, then cartilage and bone tissue repair can be achieved, but toxic side effects and limited application range occur
Solution Approach 1:
The patent introduces a nanoparticle vector as an intermediary delivery system that carries RNA molecules to target cells. The vector comprises a cationic polymer conjugated with targeting ligands (such as RGD peptides or antibodies) that specifically bind to receptors on cartilage or bone cells. This intermediary system enables selective delivery of therapeutic RNA while avoiding non-specific toxicity of conventional materials, thereby maintaining tissue repair efficacy while reducing harmful effects.
Solution Approach 2:
The patent utilizes the electronegative property of RNA molecules and employs cationic polymers with specific charge densities to form stable complexes. By adjusting parameters such as polymer molecular weight, charge density, and RNA-to-polymer ratio, the system achieves optimal cellular uptake and reduced cytotoxicity. The targeting ligands are conjugated at specific ratios to balance targeting efficiency and biocompatibility, thereby improving safety while maintaining therapeutic effect.
2Ease of operation
If conventional scaffold systems are used for cartilage tissue repair, then cell implantation can be performed, but poor targeting and large application limitations occur
Solution Approach 1:
The patent functionalizes the nanoparticle surface with specific targeting ligands (such as RGD peptides, integrin antibodies, or cell-specific receptors) that are localized at the nanoparticle surface. This local functionalization enables the nanoparticles to specifically recognize and bind to target cartilage or bone cells through receptor-ligand interactions, achieving precise cellular targeting while maintaining ease of system operation and broad applicability across different tissue types.
3Reliability
If RNA vectors are delivered using traditional methods, then gene regulation can be achieved, but metabolic degradation and lack of targeting occur
Solution Approach 1:
The cationic polymer acts as a protective intermediary that forms stable complexes with RNA molecules through electrostatic interactions. This polymer coating shields the RNA from enzymatic degradation by nucleases in the biological environment. The targeting ligands conjugated to the polymer further mediate specific binding to target cells, ensuring that the RNA reaches its destination intact and functional, thereby maintaining both stability and gene regulation efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticle vector achieves targeted delivery of RNA to cells, facilitating gene silencing and promoting cartilage and bone tissue repair in situ, with improved safety and efficacy compared to conventional methods.
Implementation Method 1
Studies have shown that RNA interference (RNAi) mediated by the delivery of gene vectors constructed from biomaterials has a certain regulatory effect on gene expression in cells
Implementation Method 2
small interfering RNA (siRNA) and small molecule RNA (MicroRNA, miRNA) are electronegative oligonucleotide molecules
Data Source
AI summary
The present disclosure discloses a nanoparticle vector for RNA self-delivery and a preparation method therefor and use thereof. The nanoparticle vector includes: a β-cyclodextrin-RNA conjugate, an adamantane-ligand conjugate, and a cationic polymer, wherein the adamantane-ligand conjugate is formed by conjugating adamantane with a ligand molecule through polyethylene glycol. Through a host-guest interaction between β-cyclodextrin and an adamantane molecule, the nanoparticle vector can realize the modular conjugation of a delivered RNA molecule and the ligand molecule, and realize the self-delivery of RNA. The polyethylene glycol molecule can avoid the recognition and phagocytosis of immune cells before the vector enters target cells, and β-cyclodextrin can realize the escape of intracellular nucleosome. The nanoparticle vector delivers RNA to cells in a targeted manner, and is degraded in vivo via endocytosis, releasing RNA molecules to inhibit expression of genes of interest, and play a role in repairing cartilage and bone tissue in situ.